1. Home
  2. Live Updates
  3. Inmune bio

Live Breaking News & Updates on Inmune bio

Stay informed with the latest breaking news from Inmune bio on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Inmune bio and stay connected to the pulse of your community

INmune Bio Independent Director Acquires 80% More Stock

Potential INmune Bio, Inc. ( NASDAQ:INMB ) shareholders may wish to note that the Independent Director, Scott Juda...

Inmune-bio , Potential-inmune-bio , Nc- , Nsider-transactions , Nmune-bio , Nsider-ownership , Cott-juda ,

INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Florida , United-states , Boca-raton , New-york , Inmune-bio , David-moss , Company-phase , Inmune-bio-inc , Company-annual-report-on-form , Company-current-reports-on-form , Exchange-commission , Drug-administration

INmune Bio (INMB) Reports 24-Month Stability Validation of XPro for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

INmune Bio (INMB) Reports 24-Month Stability Validation of XPro for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San-antonio , Texas , United-states , Inmune-bio , David-moss , Joshua-schoonover , Jason-nelson , Exchange-commission , Company-current-reports-on-form , Tho-company , Drug-administration , Nasdaq

INmune Bio Inc. Announces 24-Month Stability Validation of XPro™ for Phase III Readiness and Commercial Supply Chain Modeling & Development of Novel Immunogenicity Assay

Boca Raton, Florida, April 23, 2024 --  INmune Bio, Inc.  , a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight...

Boca-raton , Florida , United-states , San-antonio , Texas , Joshua-schoonover , Jason-nelson , Inmune-bio , David-moss , Nasdaq , Company-current-reports-on-form , Exchange-commission

INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering

Boca Raton, Florida - INmune Bio, Inc. , a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced today...

New-york , United-states , Florida , Boca-raton , Jason-nelson , David-moss , Inmune-bio , Company-quarterly-reports-on-form , Lifesci-capital , Company-annual-report-on-form , Drug-administration , Company-phase

INmune Bio Inc. Presents Data on INB03's Role as an Immune Check Point Modulator in the Treatment of High-Risk Breast Cancer at AACR 2024 -April 08, 2024 at 08:02 am EDT

Novel Immunotherapy Approach Targets Soluble Tumor Necrosis Factor to Overcome Resistance and Enhance Therapeutic Outcome in High-Risk Breast Cancer Boca Raton, Florida, April 08,...

Boca-raton , Florida , United-states , American , David-moss , Roxana-schillaci , Gil-deza , Jason-nelson , Cordo-russo , Maria-florencia-mercogliano , Inmune-bio , Joshua-schoonover

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript

INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript March 28, 2024 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.58. INMB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, greetings and welcome […]

United-kingdom , Australia , Thomas-shrader , Mark-lowdell , David-moss , Biggest-sports-betting-companies , Nowi-d , Taxed-states , Sports-betting-companies , Inmune-bio , Avid-moss , Ark-lowdell

Stocks Tread Water Before the Open as Investors Brace for U.S. Economic Data

Real-time index price for PHLX Swiss Franc (XDS), along with buy or sell indicators, analysis, charts, historical performance, news and more

United-states , Japan , Germany , Shanghai , China , San-francisco , California , Jiayin , Heilongjiang , Michigan , Hong-kong , German

Earnings Scheduled For March 28, 2024 - Ascent Industries (NASDAQ:ACNT), Achieve Life Sciences (NASDAQ:ACHV)

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million.

United-states , Jiayin , Heilongjiang , China , American , Inmune-bio , Cnfinance-hldgs , American-oncology-network , Pineapple-energy , Cheche-group , Naas-technology , Companies-reporting

Alzheimer's Disease: The Treatment Battle Heats Up Despite Eli Lilly's Setback

Alzheimer's Disease: The Treatment Battle Heats Up Despite Eli Lilly's Setback
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Switzerland , Swiss , Eli-lilly , Heatherm-snyder , William-blair , Piper-sandler , Bristol-myers-squibb , Christopher-raymond , Inmune-bio , Anne-white , Myles-minter , View-research